Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

• Introduction
• Scope and Methodology
• Summary of Findings
  • Market Size and Growth
  • Trends and Conclusions

Chapter two: Clinical Genetic Disease Testing

• What Are the Diseases Generating Revenue?
• Newborn Screening
• Competitive Analysis

Chapter Three: Direct-to-Consumer/ Over-the-Counter Genetic Testing

• Why Consumers and Not Doctors?
• DTC Marketing

Chapter four: Pharmacogenetic Testing

• The Tests
  • Her-2/Neu testing
  • HIV Resistance Testing
  • P450
  • Thiopurine Methyltransferase (TPMT)
  • Osteoporosis/Bone Loss
  • Cardiovascular
  • Immune Response
• Areas of Pharmacogenetic Development
  • Preimplantation Genetic Diagnostics
• Cancer, Cardiovascular, Mental Illness

Chapter Five: Pharmacogenetic Testing—An End-User Survey

• Her2/Neu End User Survey
  • Summary of Results
  • Conclusions
• Pharmacogenetic Testing Survey
  • Summary of Results
  • Conclusions

Chapter Six: GMO Testing

• Introduction
• Grain Inspectors Packers Standard Association (GIPSA)
• European Network of GMO Laboratories (ENGL)
• The Market & Market Players

Chapter Seven: Forensics and Paternity

• The Forensic DNA Market
• U.S. Forensic DNA Laboratories
• International Forensic DNA Testing
• Paternity Testing

Chapter eight: Conclusions & Strategic Implications

• First Conclusion
• Second Conclusion
• Third Conclusion
• Fourth Conclusion

Chapter nine: Company Profiles

• Arup Laboratories
• Athena Diagnostics
• Biogenetic Services, Inc.
• California Seed & Plant, Inc.
• DNA Sciences, Inc.
• Eurofins
• Gene Scan AG
• GeneLex
• GeneLink, Inc.
• Genetic ID
• Genzyme
• Great Smokies Diagnostic Laboratory
• HealthCheck
• HerediLab
• Investigen
• Investigen
• Labcorp
• LGC
• Medallion Labs
• Myriad Genetics, Inc.
• Neo Gen Screening
• OMIC
• Orchid Biosciences
• Quest Diagnostics
• Sciona Limited
• Silliker Labs
• Specialty Labs
• Visible Genetics/Bayer Diagnostics

Appendix A: A Note on Standards for DNA-Based Testing

Appendix B: Pharmacogenetic Tests End User Questionnaires

appendix C: Genetic Testing Glossary

Appendix D: Company Directory

List of Exhibits

Chapter one: Executive Summary

Table 1-1: Genetic Testing Revenue by Application 2000-2008

Chapter two: Clinical Genetic Disease Testing

Table 2-1: Number of Clinical Genetic Disease Tests 2000-2003

Table 2-2: Clinical Genetic Disease Testing Revenue 2000-2008

Table 2-3: Top Ten Genetic Diseases by Number of Clinical Laboratories, 2003

Table 2-4: Number of Labs Performing Genetic Disease Tests by Disease, 1998, 2000, 2002

Figure 2-1: Trending of Number of Laboratories Conducting the Top Five Clinical Genetic Test 1998-2003

Table 2-5: LabCorp Genetic Testing Volumes 1999-2002

Table 2-6: Market Share of Inherited Genetic Testing Service Providers by Leading Competitor 2002

Figure 2-2: Market Share of Inherited Genetic Testing Service Providers by Leading Competitor 2002

Chapter Three: Direct-to-Consumer/ Over-the-Counter Genetic Testing

Table 3-1: Number of Companies with DTC/OTC Genetic Tests on the Market by Disease, 2002

Table 3-2: DTC/OTC Test Areas by Company

Table 3-3: Common Inherited Genetic Disease Tests List Price by Company

Table 3-4: Sciona Nutrigenetic Panel

Table 3-5: Myriad Breast Cancer & Cardia Risk Revenue 1997 and 2001

Chapter four: Pharmacogenetic Testing

Table 4-1: Pharmacogenetic Tests by Company

Table 4-2: Number of Her2/Neu Testing Procedures 2000-2008

Table 4-3: Diseases for Which Tests Were Available 2000

Chapter Six: GMO Testing

Table 6-1: Pecentage of Global Crops Genetically Modified by Type 2001-2002

Table 6-2: Global Genetically Modified Crop Production by Country

Table 6-3: Pecentage of GM-Crop Used in the United States

Table 6-4: Number of "Deficient" DNA Testing Laboratories

Table 6-5: Number of Public GIPSA DNA GMO Labs by Country

Table 6-6: DNA GMO Testing Revenue 2000-2008

Table 6-7: DNA GMO Testing Laboratories

Table 6-8: Market Share of the DNA GMO Testing Players 2002

Chapter Seven: Forensics and Paternity

Table 7-1: Number of DNA Database Laws by State

Table 7-2: Number of State All Felon DNA Database Laws

Table 7-3: Current Backlog of Forensic DNA Samples

Table 7-4: Forensic DNA Sample Revenue 2000-2008

Table 7-5: Total Forensic DNA Samples, 2001-2002

Table 7-6: Number of Forensic DNA Samples and Laboratories, 2001-2002

Table7-7: Number of CODIS DNA Samples in the Database, 2000-2003

Table 7-9: Number of Canadian Forensic DNA Samples, 2001-2003

Table 7-10: Number of Parentage Testing Cases 1998-2001

Table 7-11: Laboratories by Volume of Cases Reported

Table 7-12: Share Utilization of Various Technologies in Paternity Testing 1998-2003

chapter eight: Conclusions & Strategic Implications

Table 8-1: Tests Offered by Both Traditional Physician and DTC Services